News and Trends 12 Apr 2018 British Biotech Raises £29M Round to Fight Lung Disease Enterprise Therapeutics has raised a substantial Series B financing round to bring its treatments for respiratory diseases into clinical development. Enterprise Therapeutics, a British biotech, has raised £29M (€33M) in Series B from several investors including Forbion, one of the most active European life science VCs. In Enterprise, Forbion has found a replacement in its portfolio for the Dutch […] April 12, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
More News! 12 Apr 2018 Graphene Skin Patch Measures Blood Sugar Without a Needle Researchers in the UK have developed a skin patch that measures blood sugar levels without the prick of a needle by pulling fluid out from between hair follicles. The technology could be used for both type 1 and type 2 diabetes patients. Diabetes is a major global health problem, with the World Health Organization stating 422 […] April 12, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 11 Apr 2018 Alexion Acquires Swedish Treatment for Wilson’s Disease Alexion Pharmaceutical intends to buy Wilson Therapeutics for nearly $1Bn. Wilson is developing a first-in-class treatment for Wilson’s disease, a rare disorder that can lead to severe liver and brain damage. Alexion Pharmaceuticals, one of the most successful companies in rare diseases and known for selling one of the most expensive drugs in the world, […] April 11, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 11 Apr 2018 Dutch Organs-on-Chips Raises $20.5M in Series B Financing MIMETAS, a Dutch biotech, has raised a Series B financing round to continue developing its organ-on-a-chip platform, which could remove the need to use animals in preclinical drug testing. MIMETAS, based in Leiden, has secured $20.5M (€17M) in Series B financing from investors in Asia and Europe. The company will use the funding to develop its organ-on-a-chip […] April 11, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 11 Apr 2018 French CAR-T Developer Raises $164M Despite a Challenging Road Cellectis has raised $164M (€132M) in a follow-on offering to further develop its CAR-T technology in clinical trials, despite having mixed results in the technology’s development up until now. Cellectis, based in Paris, has closed a follow-on offering on NASDAQ, raising a total of around $164M (€132M). The funding will be used to further continue clinical development […] April 11, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Interview 11 Apr 2018 Forget Humira, a New Generation of Inflammation Treatments is on the Horizon Millions of people worldwide suffer from inflammatory diseases, and many are still waiting for effective treatments. A German company, InflaRx, might have one. We spoke to its founder and CEO, Niels Riedemann, to get the whole story about the company’s technology and its recent $106M IPO on NASDAQ. It might be hard to believe, but […] April 11, 2018 - 5 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 10 Apr 2018 Microbes Come to the Rescue to Reduce Hospital Waste Hospital waste management is no laughing matter, given that one hospital bed can produce up to 0.5 kg of waste per day. A Dutch technology is using microbes to optimize the process with anaerobic digestion. We look to hospitals and our healthcare systems at large for treatment and reassurance when we are sick, but it […] April 10, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 10 Apr 2018 New Skin Care Products Use Plant Pigment Made By Bacteria Deinove is launching a new compound made from a plant pigment that could be used in anti-aging and make-up products. Deinove, based in Montpellier, is the first company to produce pure phytoene, an anti-aging cosmetic compound, through bacterial fermentation. The company plans to launch an anti-aging and cosmetic skin care product, Phyt-N-Resist, made from their […] April 10, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Startup Scout 6 Apr 2018 Spanish Biotech Uses Microbes to Make Biofuels, Food and Detergents Today, we’re in Granada, Spain, to visit Neol Bio. The biotech recycles waste to produce oils for biofuels, nutritional supplements and cleaning detergents by culturing microorganisms with waste. Mission: Neol Bio develops sustainable ways of producing oils for a wide variety of applications, from food supplements to cleaning detergents and bioenergy. The company uses high-throughput screening to […] April 6, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 5 Apr 2018 Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech OSE Immunotherapeutics could receive up to €1.1Bn from its new partner Boehringer Ingelheim, which has set its eyes on a new type of checkpoint inhibitor being developed by the French biotech. OSE Immunotherapeutics has entered a global license and collaboration deal with Boehringer Ingelheim for the development of OSE-172, a checkpoint inhibitor antibody to treat […] April 5, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 5 Apr 2018 French Crossover Fund Raises €275M to Invest in Medical Biotechs Sofinnova Partners has launched a crossover fund focusing on European companies to support medical biotechs across all funding stages, from seed to late stage. Sofinnova Partners, the largest French biotech VC, has launched a new fund called Sofinnova Crossover I to invest in the biopharmaceutical and medical device sectors. According to Sofinnova, the €275M fund […] April 5, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 4 Apr 2018 First Rapid Molecular Diagnostics Test for Lung Infections Approved in the US Curetis is the first company to receive FDA approval to market a molecular diagnostic test for lung infections in the US. The test reduces the time taken to reach a diagnosis from several days under five hours. The FDA has given Curetis, a German biotech, the green light to launch its first-in-class Unyvero platform for diagnosing lung infections […] April 4, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email